Prothena Announces Public Offering of Ordinary Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
Prothena Corp. (PRTA) Prices 2.7M Offering at $57.50/Share
March 3, 2017 8:31 AM ESTProthena Corporation plc (NASDAQ: PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today announced that it has sold 2,700,000 of its ordinary shares at a price to the public of $57.50 per ordinary share. Gross... More

